Dislipidemia y virus de inmunodeficiencia adquirida/sida

the hiv epidemic is a public health problem at worldwide. the morbidity and mortality associated with aids have change in a significant way with the use of anti-retroviral therapy. however, it has been affected by the changes provoked in the lipoprotein metabolism, which are characterized by a rise of the very low-density lipoprotein (vldl) levels and triglycerides, an increase of total cholesterol, low-density lipoprotein (ldl). hiv-infection associated with other inflammatory factors, is a progression model of atherosclerosis. the proatherogenic lipid profile in hiv/aids persons is a high risk for the development of the coronary disease. in present paper we analyzed the contribution of both the hiv-infection and the antiretroviral therapy effect on the lipid metabolism and its therapeutical procedure.